Faculty Information - SHIGA Tsuyoshi

（Last updated : 2024-02-19 01:54:03）

SHIGA Tsuyoshi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Cardiology

Position Visiting Professor

■ Published papers

1.	Original article	Impact of anatomical position of the inflow cannula on stroke in patients with left ventricular assist devices 2022/01
2.	Case report	Successful use of digoxin for trastuzumab-related cardiotoxicity to facilitate breast surgery in a patient with metastatic breast cancer 2021/09
3.	Other	JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies 2021
4.	Original article	Changes in characteristics and outcomes in Japanese patients with heart failure from the 2000s to the 2010s: The HIJ-HF cohorts. 2020/03
5.	Other	心不全と心房細動を合併する患者における血清ジゴキシン濃度と転帰　単一施設観察研究(Serum Digoxin Concentrations and Outcomes in Patients with Heart Failure and Atrial Fibrillation: A Single-Center Observational Study) 2020/03
6.	Original article	Development and Practical Test of Quality Indicators for Palliative Care in Patients With Chronic Heart Failure. 2020/01
7.	Original article	Long-term outcome of carvedilol therapy in Japanese patients with nonischemic heart failure. 2020/01
8.	Original article	Development and validation of support tools for advance care planning in patients with chronic heart failure. 2019/10
9.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
10.	Original article	Patient Health Questionnaire-2 Screening for Depressive Symptoms in Japanese Outpatients with Heart Failure. 2019/06
11.	Original article	Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience. 2019/03
12.	Case report	A case of desmoplakin mutation and delayed arrhythmogenic right ventricular cardiomyopathy/dysplasia after atrial septal defect closure. 2019/02
13.	Case report	Successfully treated eosinophilic granulomatosis with polyangiitis relapse presenting as myocarditis and followed by multimodality imaging. 2018/10
14.	Original article	Impact of Recurrent Ventricular Tachyarrhythmia on Outcome in Japanese Heart Transplant Candidates With a Left Ventricular Assist Device. 2018/08
15.	Original article	Self-Reported Non-adherence to Medication in Japanese Patients with Cardiovascular Diseases. 2018/08
16.	Original article	Body Mass Index and Sudden Cardiac Death in Japanese Patients After Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI-II Registry. 2018/07
17.	Original article	Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure. 2018/05
18.	Original article	Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. 2018/01
19.	Original article	Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. 2017/09
20.	Original article	Effectiveness and safety of dabigatran versus warfarin in real-world Japanese patients with atrial fibrillation: A single-center observational study 2017/04
21.	Other	Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015) - Digest Version. 2017/03
22.	Case report	Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator. 2017/03
23.	Original article	Avoidance behavior associated with depressive symptoms in patients with plantable cardioverter defibrillators. 2017/01
24.	Original article	Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation 2017
25.	Original article	Depression and Outcomes in Japanese Outpatients With Cardiovascular Disease - A Prospective Observational Study - 2016/11
26.	Case report	Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography 2016/10
27.	Case report	Cardiac Sarcoidosis Masked by Malignant Lymphoma. 2016/08
28.	Original article	Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience. 2016/07
29.	Original article	Assessment of Criteria of Ventricular Late Potential Measurement Using 187-channel Signal-averaged Vector-projected High-resolution Electrocardiograph 2016/06
30.	Original article	Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation:A Single-Center Experience 2016/05
31.	Original article	A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease. 2016/04
32.	Case report	Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. 2016/04
33.	Review article	Steroid Therapy Ameliorated Myocardial Fatty Acid Metabolism With Recovery of Complete Atrioventricular Block in Cardiac Sarcoidosis. 2016/04
34.	Original article	An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia. 2016/02
35.	Original article	Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/02
36.	Original article	Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study. 2015/12
37.	Original article	Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals. 2015/10
38.	Original article	Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure. 2015/09
39.	Original article	Clinical Outcomes and Anticoagulant Intensity in Japanese Nonvalvular Atrial Fibrillation Patients ≧65 Years of Age with a CHADS2 Score 0-1 and Taking Warfarin 2015/07
40.	Original article	Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome. 2015/04
41.	Original article	Quantitation of pilsicainide in microscale samples of human biological fluids using liquid chromatography-tandem mass spectrometry. 2015/03
42.	Original article	Effect of intravenous amiodarone on QT and T peak-T end dispersions in patients with nonischemic heart failure treated with cardiac resynchronization-defibrillator therapy and electrical storm Original Research Article. 2015/02
43.	Original article	The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) study. 2015/02
44.	Original article	Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning. 2015/01
45.	Original article	Prolonged QTc interval predicts poststroke paroxysmal atrial fibrillation. 2015/01
46.	Original article	Impact of clustered depression and anxiety on mortality and rehospitalization in patients with heart failure. 2014/12
47.	Original article	Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. 2014/12
48.	Original article	Impact of the serum bone-specific alkaline phosphatase level at the initiation of hemodialysis therapy for end-stage renal disease on cardiovascular events. 2014/07
49.	Original article	Brain Natriuretic Peptide in Acute Ischemic Stroke. 2014/05
50.	Original article	Post-traumatic stress disorder and its risk factors in Japanese patients living with implantable cardioverter defibrillators: A preliminary examination. 2014/04
51.	Original article	Reversible cardiomyopathy after radiofrequency ablation of 30-year persistent atrial tachycardia. 2013/12
52.	Original article	Chronic kidney disease and long-term outcomes of myocardial infarction 2013/09
53.	Original article	Lack of Pharmacokinetic Interaction between Pilsicainide and Rifampicin in Healthy Volunteers 2013/08
54.	Original article	Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics 2013/06
55.	Review article	Intelligent Clinical Research and Innovation Center for Supporting Investigators to Develop Advanced Regenerative Medicine and Medical Devices 2013/06
56.	Original article	Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes 2013/05
57.	Other	Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias(JCS 2011)-Digest Version- 2013/04
58.	Original article	Influence of beta-blockers on the myocardial mRNA expressions of circadian clock- and metabolism-related genes. 2013/03
59.	Other	Reconsideration of anticoagulant therapy in Japanese patients with atrial fibrillation and moderate renal impairment 2013/02
60.	Original article	Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice. 2013/01
61.	Original article	Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study 2012/07
62.	Original article	Lack of Contribution of P-Giycoprotein-Mediated Transport to Renal Excretion of Pilsicainide in Humans 2012/05
63.	Other	Renal Dysfunction, Recovery Time Dispersion and Ventricular Arrhythmias in Heart Failure Patients Receiving Cardiac Resynchronization Therapy Defibrillator 2011/09
64.	Review article	Use of Antiarrhythmic Drug in Patients with Impaired Renal Function 2011/09
65.	Original article	Clinical outcome in paroxysmal or persistent atrial fibrillation patients receiving bepridil. 2011/06
66.	Original article	Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects in Japanese healthy subjects. 2011/05
67.	Original article	The Role of Echocardiography in Predicting Responders to Cardiac Resynchronization Therapy -Results From the Japan Cardiac Resynchronization Therapy Registry Trial (J-CRT) -. 2011/05
68.	Original article	Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function 2010
69.	Original article	Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function. 2010
70.	Other	Chronic Obstructive Pulmonary Disease and Hemodynamics in Patients with Systolic Heart Failure 2010
71.	Other	Do All Heart Failure Patients with Central Sleep Apnea Have Pulmonary Congestion? 2010
72.	Other	Efficacy of the Combination of Amlodipine and ARB in Hypertensive Patients with Coronary Artery Disease,CAD 2010
73.	Other	for the Refractory VT/VF,Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant(RELIEF)Study Investigators.Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. 2010
74.	Original article	Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator 2010
75.	Other	Impact of appropriate shock therapy in nonischemic heart failure patients with prophylactic implantable cardioverter defibrillator 2010
76.	Other	Impact of renal dysfunction on mortality in heart failure patients receiving cardiac resynchronization therapy 2010
77.	Other	Indication andefficacy of cardiac resynchronization therapy in heart failure patients who had not met criteria Symposium 8 indication and unsolved issues in cardiac resynchronization therapy 2010
78.	Original article	Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator 2010
79.	Other	Is reduced left ventricular ejection fraction sufficient to predict of sudden cardiac death in patients with structural heart disease? Plenary session 3 ;cardiac suddeen death:clinical evidence and treatment 2010
80.	Case report	Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia 2010
81.	Original article	Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects 2010
82.	Other	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow up at a Tertiary Hospital in Japan 2010
83.	Other	The study of the relationship between the propagation in the left ventricular activaton and the effect of cardiac resynchronization therapy 2010
84.	Other	Usefulness of body surface mapping in predictiong ventricular tachyarrhythmias after cardiac resynchronization therapy 2010
85.	Original article	Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. 2006/09
86.	Original article	Low-dose systemic phosphodiesterase III inhibitor pimobendan combined with prostacyclin therapy in a patient with severe primary pulmonary hypertension. 2003/07
87.	Original article	Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy. 2001/10
Display 5 items
Display all(87)

■ Academic conference presentation

1.	Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction （Poster notice，General） 2019/11/17
2.	Observational Report of the Prognostic Impact of Landiolol in Acute Heart Failure patients Presenting Atrial Fibrillation with Rapid Ventricular Response （Poster notice，General） 2019/11/17
3.	A case with ischemic severe heart failure improved temporary after Autologous myoblast sheets transplantation therapy, but we could not save （Poster notice，General） 2019/10/04
4.	Changes of ejection fraction among hospitalized heart failure patients: From HIJ-HFII study （Poster notice，General） 2019/10/04
5.	Relationship between B-type natriuretic peptide and various adverse outcomes in patients with apical hypertrophic cardiomyopathy （Speech，General） 2019/10/04
6.	Benefit of sinus rhythm restoration in acute decompensated heart failure patients with atrial tachyarrhythmia treated with landiolol （Abstract Only，General） 2019/09/02
7.	Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study （Poster notice，General） 2019/09/02
8.	Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients （Poster notice，General） 2019/09/02
9.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （General） 2019/09/02
10.	Incidence and Predictors of Long-term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-flow Device for Bridge to Transplant （Speech，General） 2019/04/05
11.	Myocardial Flow Reserve Using 13N Ammonia PET for Detection of Cardiac Allograft Vasculopathy （Poster notice，General） 2019/04/03
12.	Haemoglobin A1c (HbA1c) in Diabetic Patients with Myocardial Infarction: Is HbA1c an Independent Risk Factor and Predictor of Adverse Outcome? （Speech，General） 2019/03/31
13.	Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy （Poster notice，General） 2019/03/31
14.	13N Ammonia PET Myocardial Flow Reserve for Detection of Cardiac Allograft Vasculopathy in Heart Transplant Patients （Speech，General） 2019/03/30
15.	Detection of Myocardial Inflammation in Sarcoidosis Using Cardiac Magnetic Resonance T2 Mapping （Speech，General） 2019/03/30
16.	Intravenous Landiolol for Hemodynamically Unstable Ventricular Tachycardia and Ventricular Fibrillation: Outcome of J-Land Study II （Speech，General） 2019/03/30
17.	Management of Ventricular Arrhythmias in Patients with Implanted Ventricular Assist Devices （Speech，General） 2019/03/30
18.	Prognostic Impact of Discharge Serum Chloride Levels in Heart Failure Patients: An Analysis of HIJ-HF II Multicenter Cohort Study （Poster notice，General） 2019/03/30
19.	Renal Function and the Prognostic Impact of Renin-angiotensin-aldosterone System Inhibitors for Heart Failure Patients: An Analysis of HIJ-HF II Study （Speech，General） 2019/03/29
20.	Aggressive Sodium Restriction in Chronic Heart Failure: 6g vs. 3g a Randomized Study （Poster notice，General） 2019/03/16
21.	Cardiac sarcoidosis with features mimicking arrhythmogenic right ventricular cardiomyopathy （Speech，General） 2019/02/09
22.	Optimized Settings for Adaptive Servo-Ventilation in Patients With Severe Heart Failure Diagnosed Using Echocardiography （Poster notice，General） 2018/11/11
23.	A new treatment option with ipragliflozin administered additionally in a caseinvolving stage D heart failure with diabetes （Speech，General） 2018/10/13
24.	Treatment strategy for Cpc-PH after surgery of mitral valve disease; Insights from a case report （Speech，General） 2018/10/13
25.	A Case of Severe Aortic Stenosis with Mitral Regurgitation Decreased after Transcatheter Aortic Valve Implantation （Poster notice，General） 2018/10/11
26.	Cardiac Resynchronization Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia: Case Reports and Clinical Implications （Speech，General） 2018/10/11
27.	Impact of congestion in worsening renal failure after implantation of a centrifugal, continuous-flow left ventricular device （Speech，General） 2018/08/27
28.	Clinical and Electrocardiographic Characteristics in High-Risk Hypertrophic Cardiomyopathy Patients with Prophylactic Implantable Cardioverter Defibrillator （Speech，Panelist at Symposium/Workshop (Appointed)） 2018/07/13
29.	Impact of nutritional status on heart failure hospitalization and mortality in nonischemic patients with implantable cardioverter defibrillator （Poster notice，General） 2018/05/26
30.	Temporal trends in clinical characteristics, management of heart failure patients with mid-range ejection fraction in Japan: from the HIJ-HF studies （Poster notice，General） 2018/05/26
31.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/26
32.	Use of mineralocorticoid receptor antagonists in real-world patients with nonischemic heart failure and reduced ejection fraction: an analysis of HIJ-HF II study （Poster notice，General） 2018/05/26
33.	Optimized settings for adaptive servo ventilation in patients with severe heart failure based on the echocardiogram （Poster notice，General） 2018/05/19
34.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/19
35.	Long-Term Changes in Renal Function after Implantation of a Centrifugal-type, Continuous-flow Left Ventricular Assist Device （Speech，General） 2018/03/25
36.	Modified Nutrition Risk in Critically Ill (mNUTRIC) Score on Admission and Outcome in Hospitalized Patients with Acute Heart Failure （Poster notice，General） 2018/03/25
37.	The Impact of 18F-fluorodeoxyglucose Uptake on Serial Cardiac Positron Emission Tomography Guided Therapy in Patients with Cardiac Sarcoidosis （Speech，General） 2018/03/25
38.	Use of Mineralocorticoid Receptor Antagonists in Real-world Heart Failure Patients with Reduced Ejection Fraction: An Analysis of HIJ-HF II Study （Speech，General） 2018/03/25
39.	Impact of Nutritional Status on Heart Failure Hospitalization and Mortality in Patients with Implantable Cardioverter Defibrillator （Poster notice，General） 2018/03/24
40.	Long-term Survival in Heart Failure Patients Receiving Carvedilol Therpay: A 10-Year Observational Study （Poster notice，General） 2018/03/24
41.	Sufficient Reduction in FDG Uptake on Serial Cardiac-PET is Associated with Improvement of Cardiac Function in Patients with Cardiac Sarcoidosis （Poster notice，General） 2018/03/24
42.	A Case of Severe ASD-PAH "Treat and Repair" by Epoprostenol Continuous Intravenous Infusion and Surgical ASD Partial Closure （Speech，General） 2018/03/23
43.	Comprehensive Targeted Sequencing Uncovers the Genetic Basis of Cardiomyopathy and the Genotypes Involved in Prognosis and Left Ventricular Reverse Remodeling （Speech） 2018/03/23
44.	Impact of Nutritional Status on Mortality in Patients with Cardiac Resynchronization Therapy （Poster notice，General） 2018/03/23
45.	Role of Pharmacotherapy on Reducing Sudden Death in Patients with Heart Failure. （Speech，Panelist at Symposium/Workshop (Appointed)） 2018/03/23
46.	Is Disease Activity of Cardiac Sarcoidosis Suppressed During Maintenance Dose Period of Corticosteroid Therapy? Evaluation by FDG-PET （Poster notice，General） 2018/03/12
47.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （Poster notice，General） 2018/03/11
48.	Importance of physiological pacing on right heart failure in a case with left ventricular noncompaction and left ventricular assist device （Speech，General） 2017/10/13
49.	Long-term changes in renal function in patients after implantation of a centrifugal-type, continuous-flow left ventricular assist device （Speech，Panelist at Symposium/Workshop (Applied)） 2017/10/13
50.	Outcome of Severe Ischemic Heart Failure Patients Treated with Amiodarone （Poster notice，General） 2017/10/13
51.	Prognostic Implications of Concomitant Pneumonia in Acute Heart Failure Patients Who Underwent Noninvasive Positive Pressure Ventilation （Speech，General） 2017/10/13
52.	Detection of undiagnosed cardiac sarcoidosis by FDG-PET and SPECT among patients with atrioventricular block followed in a pacemaker outpatient clinic （Poster notice，General） 2017/10/12
53.	Effectiveness of sildenafil for right ventricular failure after left ventricular assisted device implantation: a case report （Speech，General） 2017/10/12
54.	Pharmacologic management of arrhythmia in heart failure （Speech，Panelist at Symposium/Workshop (Appointed)） 2017/10/12
55.	The impact of Brain atrophy in the patient with young patients with severe heart failure （Speech，General） 2017/10/12
56.	Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs （Poster notice，General） 2017/09/28
57.	TDM for cardiovascular and endocrine diseases TDM of cardiovascular drugs （Speech，General） 2017/09/27
58.	Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction （Poster notice，General） 2017/08/29
59.	The incidence and clinical significance of 18F-fluorodeoxyglucose re-uptake on cardiac positron emission tomography in patient with cardiac sarcoidosis after receiving corticosteroid therapy （Speech，General） 2017/08/29
60.	Detection of undiagnosed cardiac sarcoidosis by FDG-PET and SPECT among patients with Atrioventricular Block routinely followed in a pacemaker outpatient clinic （Poster notice，General） 2017/08/28
61.	Changes and predictive value of filtered QRS duration for mortality in non-ischemic heart failure patients with cardiac resynchronization therapy （Poster notice，General） 2017/04/30
62.	Echocardiographically estimated pulmonary artery systolic pressure predicts progressive heart failure and systemic embolic events in patients with hypertrophic cardiomyopathy （Poster notice，General） 2017/04/30
63.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure Patients with Cardiac Resynchronization Therapy （Poster notice，General） 2017/03/19
64.	Heart Team Approach for LVAD - Cooperation with Home Medical Care - （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
65.	Impact of Core Depressive Symptom in Outpatients with Heart Failure: A Multicenter Prospective Observational Patient Health Questionnaire Study. （Poster notice，General） 2017/03/19
66.	Recovery of Left Ventricular Ejection Fraction and Ventricular Arrhythmias in Heart Failure Patients: Prospects of Wearable Cardioverter Defibrillator （Speech，Panelist at Symposium/Workshop (Applied)） 2017/03/19
67.	Adherence to Medication and Characteristics in Patients with Cardiovascular Disease. From A Multicenter Prospective Observational Depression Study （Speech，General） 2017/03/18
68.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure （Poster notice，General） 2017/03/18
69.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Japanese Heart Failure Patients: From the HIJ-HF Cohort Study （Speech，General） 2017/03/18
70.	Geometric Dysfunction and Myocardial Fibrosis in Cardiomyopathy: Demonstration by 3T High-temporal Tagged CMR （Poster notice，General） 2017/03/18
71.	Activation of Effector Memory and Effecter T Cells in Patients with Heart Failure （Poster notice，General） 2017/03/17
72.	Arrhythmogenic Right Ventricular Cardiomyopathy with a Desmoplakin Mutation That Appeared after Occlusion of an Atrial Septal Defect （Speech，General） 2017/03/17
73.	Body Mass Index and Sudden Cardiac Death in Japanese Patients with Acute Myocardial Infarction: Data from JCAD and HIJAMI II （Speech） 2017/03/17
74.	Long-Term Recovery of Left Ventricular Ejection Fraction in Heart Failure Patients with Primary Prevention Implantable Cardioverter Defibrillator （Poster notice，General） 2017/03/17
75.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study （Speech，General） 2017/03/17
76.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2017/03/17
77.	The Incidence and Clinical Significance of 18F-fluorodeoxyglucose Re-uptake on Cardiac Positron Emission Tomography in Patient with Cardiac Sarcoidosis at Follow-up （Poster notice，General） 2017/03/17
78.	Activation of Effector Memory T Cells in Patients with Heart Failure （Speech，General） 2016/12/17
79.	The roll of potassium channel on T cell for effector memory and effecter T cells in patients with heart failure （Speech，Panelist at Symposium/Workshop (Applied)） 2016/12/07
80.	Plasma Levels of Cancer Antigen-125 as a Biomarker of Paroxysmal or Persistent Atrial Fibrillation in Postmenopausal Women （Poster notice，General） 2016/11/13
81.	CRT-D Replacement in a 60-year-old Woman with LBBB, No VT and LVEF 55% After CRT-D （Speech，Special/Invited Lecture） 2016/10/13
82.	Beta-blockers and Prognosis in Patients with Atrial Fibrillation and Heart Failure: From the HIJ-HF Cohort （Speech，Panelist at Symposium/Workshop (Applied)） 2016/10/09
83.	A Case of Dilated Cardiomyopathy Demonstrating Markedly Improvement from Deteriorated Renal Function by Challenging Catecholamine Infusion and Succeeding an Implantable-VAD （Poster notice，General） 2016/10/08
84.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction （Poster notice，General） 2016/10/08
85.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure with Preserved Ejection Fraction: From the HIJ-HF cohort study （Speech，General） 2016/10/07
86.	Restrictive Left Ventricular Filling Pattern and Sudden Death Risk in Japanese Patients with Hypertrophic Cardiomyopathy （Poster notice，General） 2016/10/07
87.	A novel indication of cardiac resynchronization therapy without cardioversion and defibrillation （Poster notice，General） 2016/08/30
88.	Electrocardiographic risk stratification of electrical storm in non-ischemic heart failure patients with cardiac resynchronization （Poster notice，General） 2016/08/30
89.	Impact of PHQ-2 screening in outpatients with heart failure: A Multicenter prospective observational study （Poster notice，General） 2016/08/30
90.	Impact of ventricular tachyarrhythmias in advanced non ischemic heart failure patients who referred for heart transplant evaluation （Poster notice，General） 2016/08/29
91.	Single photon emission computed tomography is the marker of cardiac event risk in cardiac sarcoidosis patients （Poster notice，General） 2016/08/29
92.	Nonsustained ventricular tachycardia in cardiac sarcoidosis is the independent marker of increased cardiac event （Poster notice，General） 2016/08/28
93.	The role of digoxin in patients with atrial fibrillation. （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/17
94.	A novel indication of cardiac resynchronization therapy without cardioversion and defibrillation （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
95.	Comparison of outcomes in patients received cardiac resynchronization therapy with and without defibrillator: a propensity-score adjusted analysis （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
96.	Risks for survival to hospital discharge in patients with intravenous class III antiarrhythmic drug for the termination of ventricular tachyarrhythmia （Speech，General） 2016/07/16
97.	Role of pharmacologic therapy for arrhythmia in heart failure （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
98.	The prognostic and therapeutic target role of atrial tachyarrhytmia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，Panelist at Symposium/Workshop (Applied)） 2016/07/16
99.	A Longitudinal Hemodynamic Study in Hemodialysis Patients with and without Pulmonary Hypertension （Poster notice，General） 2016/03/20
100.	Possible Life-saving Effect of Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy Patients with Midventricular Obstruction （Speech，General） 2016/03/20
101.	Ventricular Tachycardia is a Significant Prognostic Factor in Patients with Cardiac Sarcoidosis Regardless of Corticosteroid Therapy （Speech，General） 2016/03/20
102.	Activation of Central Effector Memory and Effecter T Cells in Patients with Heart Failure （Speech，General） 2016/03/19
103.	Electrocardiographic Risk Stratification of Electrical Storm in Heart Failure Patients with Cardiac Resynchronization （Speech，General） 2016/03/19
104.	Pharmacological Prevention of Paroxysmal Atrial Fibrillation Recurrences in Symptomatic Patients. A Multicenter Crossover Study of Flecainide and Pilsicainide （Poster notice，General） 2016/03/19
105.	Prognostic Role of Atrial Tachyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasi （Poster notice，General） 2016/03/19
106.	Extracellular Water to Total Body Water Ratio Measured by Bioelectrical Impedance Analysis and Outcome in Hospitalized Heart Failure Patients （Poster notice，General） 2016/03/18
107.	Impact of "Reactive" Pulmonary Hypertension in Severe Heart Failure Patients Who Referred for Heart Transplantation Evaluation in Japan （Poster notice，General） 2016/03/18
108.	Targeted Endomyocardial Biopsy Guidedby Electroanatomical Voltage Mapping in Patients with Suspected Cardiac Sarcoidosis. （Speech） 2015/09/20
109.	Clinical Features of Japanese Hypertrophic Cardiomyopathy Patients with Stroke and Systemic Embolic Events （Speech，General） 2015/04/26
110.	Prognostic Significance of Myocardial Fibrosis Detected by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy （Speech，General） 2015/04/26
111.	Targeted Endomyocardial Biopsy Using Electroanatomical Voltage Mapping for Patients Suspected of Cardiac Sarcoidosis （Speech，General） 2015/04/26
112.	Change in VEVCO2 during Warmup Phase of Cardiopulmonary Testing in Patients with Heart Failure and Pulmonary Hypertension （Speech，General） 2015/04/25
113.	Atrial Arrhythmia is a Marker of Disease Progression in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Poster notice，General） 2015/04/24
114.	Clinical Phases Vary with Disease Stage in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，General） 2015/04/24
115.	Muscle Wasting during Heart Failure Hospitalization: Insights from Bioelectrical Impedance Analysis （Poster notice，General） 2015/04/24
116.	Serum Bilirubin/Alanine Aminotransferase Ratio Predict Response to Tolvaptan in Hospitalized Heart Failure Patients （Speech，General） 2015/04/24
117.	Prognostic Significance of Myocardial Fibrosis Detected by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular. （Poster notice，General） 2015/03/15
118.	Prevalence and characteristics of myocardial crypts in Japanese patients referred for cardiovascular magnetic resonance （Poster notice，General） 2015/02/07
119.	Amiodarone Treatments Improve the Effector Function of Memory T Cells in Heart Failure （Speech，General） 2014/12/12
120.	Amiodarone Treatments Improve the Inflammation in Heart Failure. （Poster notice，General） 2014/11/18
121.	Predictive Value of Pulmonary Capillary Wedge Pressure for Heart Failure Hospitalization in Heart FPatients with Cardiac Resynchronization Therapy. （Speech，General） 2014/10/12
122.	Weaning From Intropic Support in Severe Heart Failure Patients Who Referred for Heart Transplantation Evaluation. （Speech，General） 2014/10/11
123.	Relationship Between Muscle Volume and Serum Myostatin Level in Patients with Heart Failure. （Speech，General） 2014/10/10
124.	Targeted endomyocardial biopsy using electroanatomical voltage mapping for patients suspected of cardiac sarcoidosis. （Poster notice，General） 2014/09/02
125.	Significance of interlead difference of tpeak-end intervals and t-wave current density alternans in long QT syndrome with icd implantation. （Poster notice，General） 2014/09/01
126.	Proarrhythmic effect of cardiac resynchronization therapu and transmural dipersion in patients with nonischemic heart failure. （Poster notice，General） 2014/08/31
127.	Proarrhythmic effect of cardiac resynchronization therapy and transmural dipersion in patients with nonischemic heart failure. （Poster notice，General） 2014/08/30
128.	Ventricular fibrillation in a young woman with cryopyrin-associated periodic syndrome. （Speech，General） 2014/08/30
129.	Long-term outcome of patients with obstructive hypertrophic cardiomyopathy with dual-chamber pacing （Poster notice，General） 2014/05/20
130.	Association between heart and ventricular arrhythmias in non-ischemic heartfailure patients receving implantable cardioverter defibrillators. （Poster notice，General） 2014/05/17
131.	Association between heart rate and ventricular arrhythmias in non-ischemic heart failure patients receiving implantable cardioverter defibrillator. （Poster notice，General） 2014/05/17
132.	Amiodarone Treatments Improve the Inflammation in Heart Failure Patient （Speech，General） 2014/03/23
133.	Blood Urea Nitrogen/Creatinine Ratio Predict Response to Tolvaptan in Hospitalized Decompensated Heart Failure Patients （Poster notice，General） 2014/03/21
134.	Changes and Predictive Value of QRS Duration for Mortality in Heart Failure Patients with Cardiac Resynchronization Therapy （Speech，General） 2014/03/21
135.	Necessity of a Comprehensive Treatment Approach for Heart Failure Patients （Speech，Panelist at Symposium/Workshop (Other)） 2014/03/21
136.	Role of Antiarrhythmic Drugs for Paroxysmal Atrial Fibrillation: Anyone, Anytime, Anywhere （Speech） 2014/03/21
137.	Thyroid Function and Outcome in Hospitalized Patients with Acute Decompensated Heart Failure （Poster notice，General） 2014/03/21
138.	Amiodarone Treatments Improve the Inflammation in Heart Failure Patients with Nonischemic Cardiomyopathy （Poster notice，General） 2013/12/11
139.	Two-Dimensional Dominant High-Frequency Map and Disease Characterization by 187ch Signal-Averaged Vector-Projection ECG （Speech，General） 2013/07/05
140.	Effect of persistent renal impairment on mortality in cardiac resynchronization therapy patients with nonischemic heart failure （Poster notice，General） 2013/05/27
141.	PHQ -9 screening for depression in hospitalized patients with heart failure （Poster notice，General） 2013/05/26
142.	Sequential Changes in CT Attenuation of the Liver and Liver Damage Due to Amiodarone: A multiparameter Survey of 45 Recent Cases （Speech，General） 2013/04/13
143.	Antiarrhythmic Drug Therapy in the ACLS Setting （Speech，Panelist at Symposium/Workshop (Other)） 2013/03/16
144.	The Prognostic Impact of Right Ventricular Dysfunction on Cardiac Resynchronization Therapy:a Study from START Study （Speech，General） 2013/03/16
145.	Treatment Target to Prevent the Occurrence of Life-Threatening Arrhythmia in Patients with Impaired Left Ventricular Function （Speech，Panelist at Symposium/Workshop (Other)） 2013/03/16
146.	New Algorithm for a Characterization of high-frequency Signals and Two-dimensional Dominant Frequency Map by 187ch Signal-averaged Vector-projection ECG （Poster notice，General） 2013/03/15
147.	Liver dysfunction induced by amiodarone therapy: evaluation by sequential CT studies （Speech，General） 2013/03/07
148.	Clinical Pharmacology Specialists in Hospitals: What Type of Contribution Is Possible? （Speech，Panelist at Symposium/Workshop (Other)） 2012/12/01
149.	Tpeak-tend dispersion and the occurrence of ventricular tachyarrhythmia in nonischemic heart failure patients receiving cardiac resynchronization therapy （Poster notice，General） 2012/08/27
150.	Drug Induced QRS Changes: Does it Matter and how Should it be Assessed? （Speech，General） 2012/05/29
151.	Offsetting Sitosterol Elevation with the Addition of Ezetimibe to Statin among ACS patients with Dyslipdemia （Poster notice，General） 2012/05/26
152.	Psychological Distress Problems in Patients with Refractory Heart Failure （Poster notice，General） 2012/05/21
153.	Efficacy of Oral Pimobendan on Weaning from Intravenous Positive Inotropic Agents in Advanced Heart Failure （Poster notice，General） 2012/03/18
154.	Prognosis of Patients with Myocardial Infarction and Left Ventricular Dysfunction:Nation-wide Comparison with JCAD and Other Major Japanese and Western Studies （Speech，General） 2012/03/18
155.	Occurrence and Risks of Life-threatening Arrhythmia in Heart Failure Patients with Cardiac Resynchronization Therapy （General） 2012/03/17
156.	Prevalence and Characteristics of Chronic Pulmonary Disease in Patients with Heart Failure （Poster notice，General） 2012/03/17
157.	Efficacy of Waon Therapy on Sleep Disorders in Patients with Advanced Heart Failure: A Pilot Study （Poster notice，General） 2012/03/16
158.	Use of antiarrhythmic drug in patients with impaired renal function （Speech，General） 2011/09/20
159.	The Differences of Hemodynamic Response Between Nicorandil and Carperitide in Patients with Acute Decompensated Heart Failure （Poster notice，General） 2011/08/30
160.	Usefulness of Speckle Tracking Echocardiography in Patient Selection for Cardiac Resynchronization Therapy 2011/08/04
161.	Three-Dimensional Low-dose Dobutamine Stress Echocardiography Predicts Left Ventricular Reverse Remodeling after Cardiac Resynchronization Therapy 2011/08/03
162.	Impact of Pulmonary Artery Pressure and Transpulmonary gradient on Long-term Outcome in Dilated Cardiomyopathy Patients with Pulmonary Hypertension （Poster notice，General） 2011/03/20
163.	Clinical Phases Vary with Time Course in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia （Speech，General） 2011/03/19
164.	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow Up at a Tertiary Hospital in Japan （Speech，General） 2011/03/19
165.	The Model for End-Stage Liver Disease Score as an Independent Predictor of Outcomes in Cardiac Resynchronization Therapy （Speech，General） 2011/03/18
166.	Heart Failure Etiology and Hemodynamic Response to Nicorandil in Patients With Acute Heart Failure Syndromes （Speech，General） 2010/08
167.	Recovery time dispersion and arrhythmic event in ischemic heart failure patients with cardiac resynchronization therapy device （General） 2009/06
168.	The influence of LV pacing in ventricular replolarzation of CRT: clinical study using body surface mapping （General） 2009/06
169.	Acute hemodynamic efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes （General） 2009/05
170.	Clinical Significance of Electrical Storm after Initiation of Cardiac Resynchronization Therapy) 2009/03
171.	Depression Persists in Patients with Implantable Cardioverter Defibrillator in Long Term) （General） 2009/03
172.	Efficacy and safety of amiodarone therapy in Japanese patients. 2009/03
173.	Recovery Time Dispersion and Arrhythmic Event in Patients with Cardiac Resynchronization Therapy Device) （General） 2009/03
174.	Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant: RELIEF Study) （General） 2009/03
175.	The Influence of VV-delay in CRT for the Ventricular Repolarization) （General） 2009/03
176.	Utility of ECG-gated MDCT to Differentiate Arrhythmogenic Right Ventricular Cardiomyopathy ,ARVC) from Ventricular Tachyarrhythmia) （General） 2009/03
Display 5 items
Display all(176)

■ Education

1990/04～1993/03

〔Doctoral course〕〔Doctorial Course〕 Clinical Pharmacology, Graduate School, Division of Medicine, Jichi Medical University, Completed, Doctor of Philosophy (Medical Science)